SNODGRASS H. RALPH 4

Accession 0001415889-18-001321

CIK 0001411685other

View on SEC.gov Company Profile

Filed

Aug 30, 8:00 PM ET

Accepted

Aug 31, 5:27 PM ET

Size

30.2 KB

Accession

0001415889-18-001321

Insider Transaction Report

Form 4

Period: 2018-08-29

VistaGen Therapeutics, Inc.VTGN

SNODGRASS H. RALPH

DirectorPRES./CHIEF SCIENTIFIC OFFICER

Transactions

Disposition to Issuer
Stock Option (Right to Buy)
2018-08-29−125,000→ 0 total
Exercise: $1.96Exp: 2027-04-26→ Common Stock (125,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2018-08-29−1,250→ 0 total
Exercise: $10.00From: 2009-12-17Exp: 2019-06-17→ Common Stock (1,250 underlying)
Award
Stock Option (Right to Buy)
2018-08-29+1,250→ 1,250 total
Exercise: $1.50From: 2018-08-29Exp: 2019-06-17→ Common Stock (1,250 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2018-08-29−125,000→ 0 total
Exercise: $3.49Exp: 2026-06-19→ Common Stock (125,000 underlying)
Award
Stock Option (Right to Buy)
2018-08-29+80,000→ 80,000 total
Exercise: $1.50Exp: 2026-11-09→ Common Stock (80,000 underlying)
Award
Stock Option (Right to Buy)
2018-08-29+2,500→ 2,500 total
Exercise: $1.50From: 2018-08-29Exp: 2019-03-24→ Common Stock (2,500 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2018-08-29−12,500→ 0 total
Exercise: $10.00From: 2012-12-31Exp: 2019-12-30→ Common Stock (12,500 underlying)
Award
Stock Option (Right to Buy)
2018-08-29+125,000→ 125,000 total
Exercise: $1.50Exp: 2026-06-19→ Common Stock (125,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2018-08-29−80,000→ 0 total
Exercise: $3.80Exp: 2026-11-09→ Common Stock (80,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2018-08-29−2,500→ 0 total
Exercise: $10.00From: 2013-03-24Exp: 2019-03-24→ Common Stock (2,500 underlying)
Award
Stock Option (Right to Buy)
2018-08-29+12,500→ 12,500 total
Exercise: $1.50From: 2018-08-29Exp: 2019-12-30→ Common Stock (12,500 underlying)
Award
Stock Option (Right to Buy)
2018-08-29+125,000→ 125,000 total
Exercise: $1.50Exp: 2027-04-26→ Common Stock (125,000 underlying)

Footnotes (9)

[F1]The reporting person agreed to cancellation of an option granted to him on 3/24/2009 in exchange for a new option having a lower exercise price.
[F2]The reporting person agreed to cancellation of an option granted to him on 6/17/2009 in exchange for a new option having a lower exercise price.
[F3]The reporting person agreed to cancellation of an option granted to him on 12/30/2009 in exchange for a new option having a lower exercise price.
[F4]The reporting person agreed to cancellation of an option granted to him on 6/19/2016 in exchange for a new option having a lower exercise price.
[F5]The option vests monthly over a period of four years commencing 6/19/2016.
[F6]The reporting person agreed to cancellation of an option granted to him on 11/9/2016 in exchange for a new option having a lower exercise price.
[F7]The option vests monthly over a period of three years commencing 11/9/2016.
[F8]The reporting person agreed to cancellation of an option granted to him on 4/26/2017 in exchange for a new option having a lower exercise price.
[F9]The option vests monthly over a period of three years commencing 4/26/2017.

Documents

1 file

4
form4-08312018_020835.xmlPrimary

Issuer

VistaGen Therapeutics, Inc.

CIK 0001411685

→

Entity typeother

Related Parties

filerCIK 0001415876

Filing Metadata

Form type: 4
Filed: Aug 30, 8:00 PM ET
Accepted: Aug 31, 5:27 PM ET
Size: 30.2 KB

View on SEC.gov